AQR Capital Management’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q2 | – | Sell |
-28,069
| Closed | -$115K | – | 2420 |
|
2018
Q1 | $115K | Hold |
28,069
| – | – | ﹤0.01% | 2193 |
|
2017
Q4 | $131K | Hold |
28,069
| – | – | ﹤0.01% | 2190 |
|
2017
Q3 | $199K | Buy |
+28,069
| New | +$199K | ﹤0.01% | 2169 |
|
2015
Q1 | – | Sell |
-72,379
| Closed | -$1.02M | – | 2401 |
|
2014
Q4 | $1.02M | Sell |
72,379
-11,200
| -13% | -$158K | ﹤0.01% | 1632 |
|
2014
Q3 | $1.15M | Sell |
83,579
-10,400
| -11% | -$143K | ﹤0.01% | 1543 |
|
2014
Q2 | $1.45M | Sell |
93,979
-2,900
| -3% | -$44.6K | ﹤0.01% | 1451 |
|
2014
Q1 | $1.65M | Sell |
96,879
-25,700
| -21% | -$438K | 0.01% | 1422 |
|
2013
Q4 | $1.59M | Hold |
122,579
| – | – | ﹤0.01% | 1486 |
|
2013
Q3 | $1.24M | Buy |
122,579
+11,000
| +10% | +$111K | ﹤0.01% | 1558 |
|
2013
Q2 | $833K | Buy |
+111,579
| New | +$833K | ﹤0.01% | 1661 |
|